Product Description
Since last many years Saintroy Lifescience is leading manufacture, export and supplier of Capecitabine Tablets from Surat, Gujarat, India. Capecitabine Tablets used to treat breast cancer, gastric cancer and colorectal cancer.
Tags: Capecitabine Tablets manufacturer, Capecitabine Tablets exporter, Capecitabine Tablets supplier, and Capecitabine Tablets , whogmp approved a decitabine Tablets manufacturer andsupplier, Capecitabine Tablets distributor,Capecitabine Tablets drop shipper, Capecitabine Tablets 500 mg, Capecitabine Tablets 500 mg supplier, Capecitabine Tablets 500 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples,COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Capecitabine Tablets export to USA, Canada, Germany, Europe,France, Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon,Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand,Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, Ivory Costa, Oman, Guatemala,Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia,Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan,Uzbekistan, Kazakhstan.
Comprehensive Therapy for Cancer TreatmentCapecitabine Tablets offer targeted therapy for various types of cancer, including primary and metastatic forms of colorectal and breast cancer. Available in 150 mg and 500 mg strengths, these tablets serve as a convenient oral option prescribed by healthcare professionals. Each box contains secure blisters to maintain medication integrity, ensuring reliability for patients undergoing cancer therapy.
Safe Administration and Dosing InstructionsTo achieve optimal therapeutic results, Capecitabine Tablets must be taken with water within 30 minutes after consuming a meal. Adhering to this routine enhances drug absorption and effectiveness while minimizing side effects. Always follow your oncologist's prescribed dose and avoid self-medication or dose adjustments without consultation.
FAQ's of Capecitabine Tablets:
Q: How should I take Capecitabine Tablets for effective results?
A: Capecitabine Tablets should be swallowed whole with water within 30 minutes after finishing a meal, as this improves absorption and helps reduce stomach upset. Always follow the dosing schedule provided by your doctor.
Q: What conditions are Capecitabine Tablets prescribed for?
A: Doctors prescribe Capecitabine Tablets as part of the treatment for colorectal cancer, metastatic colorectal cancer, breast cancer, and metastatic breast cancer, depending on individual patient needs and responses.
Q: When is the best time to take my dose of Capecitabine Tablets?
A: You should take your Capecitabine dose with water no later than 30 minutes after a meal, at the same times each day as directed by your healthcare provider, to maximize the medication's effectiveness.
Q: Where should I store Capecitabine Tablets after purchasing them?
A: Store Capecitabine Tablets below 30C in a dry environment, protected from moisture. Use within two days after opening and keep blister packs securely closed to maintain potency.
Q: What are the main inactive ingredients present in Capecitabine Tablets?
A: Aside from Capecitabine, these tablets contain lactose monohydrate, croscarmellose sodium, hydroxypropyl methylcellulose, microcrystalline cellulose, magnesium stearate, and titanium dioxide as part of the coating.
Q: What is the benefit of using Capecitabine Tablets over other dosage forms?
A: Capecitabine Tablets provide a convenient oral cancer therapy that can be taken at home, reducing the need for frequent hospital visits compared to intravenous treatments, while offering effective control of both early and advanced cancers.